Skip to main content
Smart Investors Daily
SS

NASDAQ · SSII

SS Innovations International, Inc.

Healthcare · Medical - Devices

$3.83

Up+$0.15 (+3.92%)

Updated Aug 14, 2026, 5:13 PM

SID Score

3.6/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
1.11B
P/E ratio
-64.95
Dividend yield
0.00%
52-week range
$3.22 – $5.25
Volume
48.05K
Avg. volume
97.55K

Price performance

SSII price history

1M range · 21 trading sessions · Daily adjusted prices

SSII closed at $3.83 after 21 trading sessions, up 6.09% for the selected period.

Last close
$3.83
Period change
+6.09%
Period low
$3.48
Period high
$3.99
Daily close
View OHLC price history
SSII OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 13, 2026$3.70$3.97$3.70$3.8348.05K
Aug 12, 2026$3.64$3.80$3.64$3.6917.54K
Aug 11, 2026$3.77$3.78$3.60$3.619.08K
Aug 10, 2026$3.78$3.88$3.71$3.7518.54K
Aug 7, 2026$3.75$3.795$3.62$3.7737.12K
Aug 6, 2026$3.87$3.87$3.66$3.7114.47K
Aug 5, 2026$3.90$3.935$3.60$3.85109.22K
Aug 4, 2026$3.92$3.95$3.75$3.83122.41K
Aug 3, 2026$4.00$4.00$3.875$3.9517.47K
Jul 31, 2026$3.96$4.11$3.85$3.9833.12K
Jul 30, 2026$4.00$4.06$3.75$3.9960.74K
Jul 29, 2026$3.93$4.025$3.72$3.8571.44K
Jul 28, 2026$4.05$4.1462$3.8561$3.93109.25K
Jul 27, 2026$3.50$4.10$3.4014$3.96239.58K
Jul 24, 2026$3.54$3.69$3.37$3.475144.62K
Jul 23, 2026$3.51$3.9312$3.36$3.57258.19K
Jul 22, 2026$3.61$3.725$3.48$3.5816.6K
Jul 21, 2026$3.61$3.77$3.55$3.5840.83K
Jul 20, 2026$3.62$3.86$3.46$3.7552.91K
Jul 17, 2026$3.55$3.71$3.49$3.6415.55K
Jul 16, 2026$3.50$3.63$3.4803$3.6144.44K

Latest SSII news

The latest Smart Investors Daily articles mentioning SSII.

SSII research

Overview

Company profile and research snapshot.

Company profile

SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
SSII recent ratings
DateFirmRatingTarget
Jun 3, 2026LUCID CAPITAL MARKETSBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 15, 2026

What SS Innovations International (SSII)'s 2025 Revenue Surge and Leadership Shift Means For Shareholders

SS Innovations International recently issued preliminary, unaudited guidance indicating fourth-quarter 2025 revenue of about US$15.0 million and full-year 2025 revenue of about US$43.0 million, both sharply higher than 2024 levels, alongside new product launches and senior leadership changes. An interesting angle for investors is the rapid build-out of the SSi Mantra surgical robot installed base, supported by new 5-millimeter instruments and an incoming Global Chief Operating Officer and...

Yahoo · Jan 14, 2026

Is SS Innovations International (SSII) Overvalued After Recent Share Price Rebound And Premium P/S Multiple

SS Innovations International (SSII) has drawn investor attention after recent trading, with the stock up 10.8% over the past day and 2.8% over the past week, contrasting with a 33.9% decline over the past 3 months. See our latest analysis for SS Innovations International. That recent 1 day share price return of 10.84% at a share price of $5.93 stands against a 90 day share price return of 33.96% decline and a 1 year total shareholder return of 26.79% decline. This suggests short term momentum...

Yahoo · Jan 13, 2026

SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025

Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic systemFORT LAUDERDALE, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced preliminary unaudited revenue and other select operating metrics for the three and twelve months en

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.